论文信息 - An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). - 字舞流文

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs).

D. Mendrick | Jackye Peretz | R. Wange | T. Bourcier | J. Bonzo | Shwu-Luan Lee | Paul C. Brown | M. Saulnier | I. Bebenek | J. Merrill | Amy M Avila | Karen L Davis Bruno | David B. Carlson | John Dubinion | I. Elayan | W. Harrouk | Emily Place | Jia Yao | Dong Zhao | Jackye R. Peretz